Empagliflozin

🧮 Dose calculator

Type 2 diabetes mellitus · Regimen source: FDA Jardiance · 2.2, Table 1

• • If tolerated may increase to 25 mg for more control. Not recommended for glycaemic control with eGFR <30. Correct volume depletion first. FDA Jardiance · 2.2FDA Jardiance · 2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Jardiance · 8.1

  “Risk Summary Based on animal data showing adverse renal effects, JARDIANCE is not recommended during the second and third trimesters of pregnancy.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Jardiance · 8.2

  “Risk Summary There is limited information regarding the presence of JARDIANCE in human milk, the effects of JARDIANCE on the breastfed infant or the effects on milk production.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Jardiance · 8.4

  “The safety and effectiveness of JARDIANCE as an adjunct to diet and exercise to improve glycemic control in type 2 diabetes mellitus have been established in pediatric patients aged 10 years and older.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Jardiance · 8.5

  “… %, and 15.1% in patients randomized to placebo, JARDIANCE 10 mg, and JARDIANCE 25 mg, respectively [see Warnings and Precautions (5.2) and Adverse Reactions (6.1) ] .”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.